ArticlePlant physiology2026
The C-terminal tail of Cf resistance proteins determines the intensity of the effector-triggered hypersensitive response-related cell death.
Article in Plant physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Cf resistance proteins of tomato that provide resistance against the extracellular fungal pathogen Fulvia fulva are receptor-like proteins (RLPs) localized at the cell surface. As they lack a cytoplasmic kinase domain, Cf proteins require 2 co-receptors to activate downstream immune responses. In the resting state, Cf proteins constitutively interact with the receptor-like kinase (RLK) SUPPRESSOR OF BIR1-1 (SOBIR1), whereas upon recognition of the matching avirulence (Avr) effector, the RLK BRI1-ASSOCIATED KINASE 1 (BAK1) is recruited. Cf proteins have a typical leucine-rich repeat (LRR)-RLP structure, consisting of an LRR ectodomain, a transmembrane domain, and an intracellular juxtamembrane domain that is referred to as the C-terminal tail. Cf-4 and Cf-9 have identical C-terminal tails, while the C-terminal tails of Cf-2 and Cf-5 differ by a single amino acid. Interestingly, the Cf-5/Avr5- and Cf-2/Avr2-triggered immune response results in a slower and weaker hypersensitive response (HR)-related cell death than the response triggered by Cf-4/Avr4 and Cf-9/Avr9. Domain swapping between Cf-5 and Cf-9 revealed that the C-terminal tail plays a specific role in determining the intensity of the immune response. Notably, the pool of SOBIR1-associated Cf-4 and Cf-9 proteins is much larger than that of Cf-2 and Cf-5, and a full-length C-terminal tail is required for immune signaling activation. This work provides a basis for further studies on RLP engineering to enhance crop resistance against detrimental pathogens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.